Compass Pathways is a new IPO that shot up the NASDAQ charts over the past week. Investors are jumping on the stock because...
RLFTF remains one of our favorite COVID-19 plays here at Insider Financial. In our last profile of the company, we focused on...
Let’s face it, COVID-19 isn’t going away anytime soon. While we have nailed many Big Board COVID-19 plays like Moderna, Inovio Pharmaceuticals, and...
NWBO stock has been depressed for a number of years after suffering a relentless short and distort campaign led by the so-called “Night...
Anyone that has followed us for quite some time knows that we have been bullish on Sorrento stock since the COVID-19 pandemic started....
Here at Insider Financial, we specialize in finding momentum BEFORE it happens. We look for bottoming patterns, breakouts, and catalysts that are...
Carson Block and Muddy Waters Research are out with another hit piece. This time it’s on Inovio stock. This isn’t the first time...
There was a lot of profit-taking and selling in many COVID-19 plays in August. Some names did get ahead of themselves and...
We last profiled Opko stock earlier this summer before the run to $6, which you can read here. However, in the past...
For the past year, shares of Trevena (NASDAQ:TRVN) haven’t really done much. The last time we did a Trevena stock forecast was in...